Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (759)	3/26/2007 1:52:30 PM
From: keokalani'nui	Respond to of 824

Time to do it is now. Let the acquirer think they can expand the market.

To: rkrw who wrote (759)	3/26/2007 4:28:20 PM
From: keokalani'nui	Read Replies (2) \| Respond to of 824

"Insane pricing"... It is really bugging me. I have to think the world is now out to get around this price at any cost. Not only is even a modest co-pay going to be a problem that alxn will eventually eat, I guess, if the patient is otherwise destitute, but some private insurance policies have maximum defined benefits which will surely be exceeded over the 10-yr thrombosis risk period. What then? Plus, I could easily see NICE now saying 'only for t-denpendent pts and then 6-months on 6-months off.' And as for market expansion for heavens sake, what symptoms could a person who is currently undiagnosed possibly have that would justify the gouging given by this exhorbitant drug for rest of life? "You haven't needed this so far, and I am pleased to inform you there is a miracle treatment for your condition. You may want to call a mortgage lender." I don't understand any of this from an expert's POV, from any angle. As an investor I don't think I'm going to hang around to hear the screaming. Good luck and goodby alexion.